In our model, NAPQI is produced in the liver by three cytochrome oxidases, CYP2E1, CYP3A4, and CYP1A2
Complementary work has documented activation of the VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) pathway, involved in angiogenesis, along with upregulation of early growth response genes (Egr-1) and the FAK-paxillin transcription factor in studied endothelial cells
We find that those affected with stage 3 have the lowest overall levels of GPx3 and display non-overlapping 95% confidence intervals as compared to their unaffected siblings (95% CI Stage 3 [0.93 g/ml, 1.36 g/ml], 95% CI Unaffected [1.78 g/ml, 2.23 g/ml]) (Fig
However, individual responses vary considerably, and not all patients experience subjective energy increases